Anaeropharma Science, Inc.

Anaeropharma Science, Inc.

Anaeropharma Science, Inc.

Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics.
Raised
$13.2M
Follow us
Alexa global traffic share
Team Size
10+
Employees
Location
Headquarters
$13,200,000 Venture capital
AVCJ , prnewswire

French VC joins $13m round for Japanese biopharma player

Funding Asia